Scientists use nano-diamonds to light up tumours
9 October 2015 | By Victoria White
The nano-diamonds could be used to identify cancerous tumours before they become life-threatening...
List view / Grid view
9 October 2015 | By Victoria White
The nano-diamonds could be used to identify cancerous tumours before they become life-threatening...
9 October 2015 | By Victoria White
When using the shRNA in breast cancer cells, Nav1.5 levels were 'knocked down', resulting in reduced tumour growth rates and metastasis...
9 October 2015 | By Victoria White
Researchers reported that treatment with IFNβ-gene therapy successfully prevented neuronal death and disease effects in an experimental model of the disease...
8 October 2015 | By Victoria White
The breakthrough could allow the use of mini-organs to screen drugs either for the treatment of kidney disease or to find out if a new drug is likely to injure the kidney...
8 October 2015 | By Victoria White
Acceleron reported the results at the 20th International Annual Congress of the World Muscle Society (WMS)...
8 October 2015 | By Victoria White
Researchers have eradicated a specific type of breast cancer tumour in mice by disabling a cancer-causing pathway and administering an immune-molecule based mop-up therapy...
8 October 2015 | By Victoria White
NKTR-214 is a CD122-biased immune-stimulatory cytokine that is designed to stimulate the expansion and maintenance of CD8-positive effector T-cells...
7 October 2015 | By Victoria White
The Cancer Research UK Centres Network Accelerator Award provides infrastructure support to research centres in order to encourage collaboration between different organisations and boost ‘bench to bedside’ science...
7 October 2015 | By Victoria White
C4XD’s most advanced compound, an oral Orexin-1 antagonist for the treatment of addiction, is in formal preclinical safety and toxicity studies...
7 October 2015 | By Victoria White
The Cell History File has been designed to fulfil the role of a ‘cell passport’ that can accompany a tissue or cell derived product as it progresses through various processing stages...
7 October 2015 | By SMi Group
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
6 October 2015 | By Victoria White
Cardiff University immunologists have described how an immune system protein - interleukin-27 - regulates the inflammatory process in lymphoid-rich rheumatoid arthritis...
6 October 2015 | By Victoria White
The new building is designed to support the Company’s continuing growth of its research and development operation and is scheduled for delivery in late 2016...
6 October 2015 | By Victoria White
Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...